Although we find evidence of a broader group of MLV-related viruses, rather than just XMRV, in patients with CFS and healthy blood donors, our results clearly support the central argument by Lombardi et al. Lo et al.
Indeed, it is possible that the PCR primers used in various studies may have different sensitivity in detecting the diverse group of MLV-related virus gag gene sequences that we found in the clinical samples. The 5′ gag leader sequence of previously described XMRVs represents the most divergent segment of the XMRV genome in comparison with the genomes of the other MLVs (4). In particular, there is evidently a unique 15-nt deletion in the 5′ gag leader region in all of the XMRVs previously iden- tified in patients with prostate cancer and CFS (3, 4). To detect XMRVs in human samples with better sensitivity and specificity, some studies used a PCR primer spanning this unique deletion as the XMRV-specific primer (6). However, none of the viral gag gene sequences amplified from the blood samples of CFS patients and blood donors in our study has this particular deletion (Fig. S1). As a consequence, such primers might have been in- sensitive in detecting the MLV-related gag gene sequences that we have identified. Lo et al.
In sum, none of the four studies that have failed to confirm the PCR evidence reported by Lombardi et al. (3), nor our own study, has attempted to fully replicate that study. Lo et al.
we suspect that the association will be lower in CFS cases identified through com- munity-based surveys, Lo et al.
Dr Alter: "Does raise questions because there isn't consensus in different CFS populations. Many things still have to be looked at. It does at least confirm the findings of Whittemore Peterson. I think one wants to go back to their studies because they have had more time and more they have done extensive work... so its not just finding isolated viral sequences. But they have found gag, env sequences. They have been able to transmit this to an animal model (the macaque). They have seen antibody in the macaque and they have seen ab in pts and they have seen the viral particles. So this study is more advanced than ours. But with them having done the groundwork, I think our study is highly confirmatory of their work and we are in the process of trying to culture virus from our patients and to find antibodies. We have already shown that some of our pts also have envelope sequences, and preliminary work appears that there is antibody present as well but this has not been confirmed. But there are many things that need to be done, many more CFS populations that need to be tested. (More) numbers of blood donors that need to be tested. Other diseases that need to be tested. More culture work. More robust assays."
Dr Lo. "No, actually this group of virus that we call polytropic MLV this is actually more characteristic for the retrovirus infection instead of a single viral gene. They very quickly can evolve and have multiple different kind of a sequence found. In fact what we found is that actually gave us good confidence that this cannot be a laboratory artifact or PCR contamination product because the sequences they are so varied from one patient to another."
Dr Alter. "My thought came back. Since their original publication the WPI and NCI groups have now found that they too are finding greater variability among their patients, so it is not just XMRV even in the original cohort of patients."
Dr McCluskey: "One thing that hasn't been mentioned so far is that this virus at least in our hands is present in a variable titre which increases the difficulty of detection so that may be also complicating or adding to the variability among the labs."
Dr Lo: "I would also add on this. I think most of the irregularity or the different findings. Many probably due to a very low copy or viral gene copy in the blood and that is a main concern for a consistent finding and using different kind of assay systems."
Dr Lo: In a way it was a little bit surprise when the WPI's first publication in Science and they show it as a single kind of kind of a sequence. That is unusual for retrovirus, but now they are also stating they do see the variation of the sequence and also appear to be more closely related to polytropic related MLV's.
The other factor the FDA response cited was differences in sample preparation. Since that's all they stated they stated its difficult to know what they were referring to. The Alter/Lo group found that testing plasma cut their positive rates in half compared to whole blood. The CDC used plasma - but so did the WPI in the original Science paper - and they, of course, had results similar to the Alter/Lo study. The FDA response did not, interestingly, suggest that they believed other problems with methodology played a role. However, the Alter/Lo paper in PNAS discussed primer problems which may be similar to those Dr. Mikovits referred to in her video.
Lauren: "It would seem to suggest more of a process of chance than a firm association."
Dr Lo. "No, actually this group of virus that we call polytropic MLV – this is actually more characteristic for the retrovirus infection instead of a single viral gene. They very quickly can evolve and have multiple different kind of a sequence found. In fact what we found is that actually gave us good confidence that this cannot be a laboratory artifact or PCR contamination product because the sequences they are so varied from one patient to another."
Lauren: "So that means it's probably not lab contamination?"
Dr Lo. "Right, exactly. Normally the PCR lab contamination you more or less anticipate that all the sequences will be the same."
Lauren: "But what I was thinking of was not lab contamination, but rather you are finding essentially multiple different kinds of viruses withing the same family."
Dr Lo: "Right they are in the same family. They are compatible with the earlier finding of the XMRV. They are not identical, they are more diverse."
The nonsense was for the facts that were nonsense. As in, don't make sense, not factual, nothing more. You have been changing your article, so it's not a case of saying they are there. The quotes are not aimed at you, they are information for everyone else who doesn't want to read the paper, but likes to at least interpret things for themselves.
camas - Today
Science has an article up on the latest findings. I thought everyone might take heart from the last sentence of the last paragraph:
Subtle differences in sample collection and handling, or in the way tests are performed, could also have led the four labs to miss the virus. But CDC’s Monroe says he’s confident that his lab can identify XMRV correctly. As part of the NHLBI program, researchers at FDA, CDC, WPI, and other labs have all blindly tested a panel of samples, some of them “spiked” with different amounts of the virus; all of them performed well. Further exchange of samples and reagents is now under way. “They should be able to clear this up by Christmas,” says Kurth.
Arrrrgghhh. Nothing in there was 'nonsense' I assure you. This *(79w2$)P)*()* is nonsense - it doesn't mean anything. Changing something does not mean what was there was there before was 'nonsense'.
I'm checking out of our lovely conversation, though. Hopefully I'll be back tonight with an addition to the paper that I think will be enlightening - it certainly was to me.
I'll be back tonight with an addition to the paper that I think will be enlightening - it certainly was to me.
That's very true, all possibilities are still open, but some just got a bit weaker.Even when the CDC is able to detect the virus in a panel of samples it is still possible that they have problems with collecting/storing/handling the samples before the actual testing. Especially when they used plasma. It could be critical to immediately centrifuge whole blood to get the plasma, because the longer the blood is stored before centrifugation, the more time antibodies in the blood have to form complexes with the virions and those antibodies can make those virion adhere to cells in the blood (macrophages express Fc-receptors that bind antibodies etc.) and the more time virions will have to attach to blood cells with their surface proteins as they do when they infect new cells. This would cause most if not all virions to end up at the bottem of the centrifugation tubes after centrifugation and this pellet is not tested for virus when they use the plasma.
This is just my thinking about this matter, i do not claim it is correct, only an hypothesis.
About myself: I'm a CFS patient for 6 years, not able to study 90% of that time and only able to progress towards my degree in biomedical sciences at a very slow pace. But i won't give up and the current science does give me hope, although i would rather have something else than a retrovirus, it is certainly better than being labeled as a psychiatric patient!
...
I don't suppose I'm the only one here who thinks V99's personal attacks on you are way out of line. She makes some valid points - amidst the misunderstandings - but they are wrapped up in so much unnecessary bile that it makes the forum an unpleasant place to be for everyone else, let alone you.
....
Totally agree.
Jeeeesh people seriously...
This stuff is super difficult, especially for the brainfogged ( like me). I apreciate all the hard work that Cort does and I love reading his articles. I am sure they are not perfect and contain some assumptions or errors that is unavoidable at this stage. Great if people can point these (assumptions/mistakes) out and improve the info out there. But the personal attacks against Cort, I find them very distressing. He is not the enemy, he is human, allowed to make mistakes and allowed to have unpopular opinions if he chooses to. I can't explain it well but this all makes me so sad.